Market Place
Sourcing Support
Innovent Eyes China Approval After Matching Eylea In Phase 3
24 Mar 2026 //
FIERCE BIOTECH
Bayer Tees Up Kerendia For Major CKD Label Expansion
16 Mar 2026 //
FIERCE PHARMA
Bayer`s 225Ac-PSMA-Trillium Results in Advanced Prostate Cancer
27 Feb 2026 //
BUSINESSWIRE
Bayer’s Xofigo Plus Enzalutamide Boosts OS in PEACE-3 Trial
26 Feb 2026 //
BUSINESSWIRE
Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg
20 Feb 2026 //
EXPRESSPHARMA
Alvotech Finalizes Global Deal For Eylea 2mg Biosimilar
29 Jan 2026 //
GLOBENEWSWIRE
Bayer, Vanderbilt Advance Cardio-Kidney Treatments
20 Jan 2026 //
PHARMIWEB
Bayer Acquires Pan-Amyloid Radiotracers For Molecular Imaging
12 Jan 2026 //
BUSINESSWIRE
Bayer, Cradle Collaborate To Boost AI Antibody Discovery
07 Jan 2026 //
PR NEWSWIRE
Bayer Sues Moderna, J&J And Pfizer/Biontech Over COVID Vax Tech
07 Jan 2026 //
FIERCE PHARMA
Vividion Publishes WRN Inhibitor VVD-214 in J. Med. Chem
06 Jan 2026 //
BUSINESSWIRE
Bayer sues COVID vaccine makers over mRNA technology
06 Jan 2026 //
REUTERS
Vividion Unveils First-in-Class KEAP1 Activator for Oncology
22 Dec 2025 //
BUSINESSWIRE
Galmed`s Late-Breaking Abstract Accepted at HEP-DART Meeting
08 Dec 2025 //
PR NEWSWIRE
Daré Bioscience Regains Ovaprene Rights, Shares Phase 3 Update
01 Dec 2025 //
GLOBENEWSWIRE
Bayer Unveils Positive Phase III Anticoagulant Data
23 Nov 2025 //
BUSINESSWIRE
US FDA approves Bayer Drug for Specific Type of Lung Cancer
20 Nov 2025 //
REUTERS
Galmed Announces Top-line Results in Oncology MoA Studies
17 Nov 2025 //
PR NEWSWIRE
Bayer Bails On Vividion Tumor Drug In Early-Stage Clear-Out
12 Nov 2025 //
FIERCE BIOTECH
Bayer`s Kerendia Succeeds in Phase 3 Trial for Type 1 Diabetes
06 Nov 2025 //
BUSINESS WIRE
Bayer Scores FDA Nod For Nonhormonal Menopause Drug
25 Oct 2025 //
BUSINESSWIRE
Askbio Publishes 12-Month Phase 1 AB-1002 Gene Therapy Trial
21 Oct 2025 //
GLOBENEWSWIRE
ESMO: Exelixis` TKI Reduces Risk Of Death By 20%
20 Oct 2025 //
FIERCE BIOTECH
Bayer Advances Gene And Cell Therapy Pipeline For Parkinson
13 Oct 2025 //
ECONOMICTIMES
AskBio Reports Interim Safety Ph1/2 Results for AB-1003 in LGMD
10 Oct 2025 //
GLOBENEWSWIRE
Bayer, Kumquat Start Phase I Trial For KRAS G12D Inhibitor
10 Oct 2025 //
INDPHARMAPOST
Bluerock Therapeutics Reveals Positive 36-Month Phase I Trial
07 Oct 2025 //
BUSINESSWIRE
AskBio to Present Six Studies at ESGCT 2025 Annual Meeting
02 Oct 2025 //
GLOBENEWSWIRE
Lung Cancer Research Foundation Reveals LCRF|bayer Research
30 Sep 2025 //
PR NEWSWIRE
Bayer Leads Cell and Gene Therapy Advances for Parkinson’s
22 Sep 2025 //
BUSINESSWIRE
Bayer Opens New Phytomedicines Lab Facility
18 Sep 2025 //
INDPHARMAPOST
ProBioGen Leads GMP Manufacturing at Berlin Gene & Cell Therapy
17 Sep 2025 //
INDPHARMAPOST
Bayer-Allied NextRNA Therapeutics Winds Down Operations
12 Aug 2025 //
FIERCE BIOTECH
UK Regulator Greenlights Bayer`s Nonhormonal Menopause Drug
11 Jul 2025 //
FIERCE PHARMA
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs
26 Jun 2025 //
FIERCE BIOTECH
Bayer, Broad Institute Extend Collaboration for Cardio Therapies
11 Jun 2025 //
BUSINESSWIRE
Bayer and BlueRock`s Journey in Cell Therapy Future
02 Jun 2025 //
FIERCE BIOTECH
Bayer Cell Therapy Plant In California Earns LEED Platinum
28 May 2025 //
INDPHARMAPOST
AskBio Shares Ph1b Results for AB-1005 in Parkinson
27 May 2025 //
GLOBENEWSWIRE
FDA approves Jivi® for pediatric hemophilia A
19 May 2025 //
BUSINESSWIRE
ConcertAI, Bayer Partner to Accelerate Precision Oncology
22 Apr 2025 //
BUSINESSWIRE
Bayer moves allogeneic cell therapy into Ph 3 Parkinson`s trial
14 Jan 2025 //
FIERCE BIOTECH
Regeneron to expand high-dose Eylea`s label after Ph 3 win
18 Dec 2024 //
BIOSPACE
Bayer and Dewpoint sign Licensing Agreement for Heart Disease Program
25 Oct 2024 //
GLOBENEWSWIRE
Bayer hopes to expand Nubeqa`s prostate cancer reach with chemo-free regimen
16 Sep 2024 //
FIERCE PHARMA
Bayer To Present New Prostate Cancer Data At ESMO 2024
05 Sep 2024 //
BUSINESSWIRE
Bayer pens $547M biobucks pact with biotech pushing the noncoding RNA
29 Aug 2024 //
PRESS RELEASE
FDA grants fast track designation to AskBio’s AB-1005 for PD
12 Jul 2024 //
PHARMACEUTICAL-TECHNOLOGY
Burning Rock Biotech collaborates with Bayer to develop NGS
03 Jun 2024 //
PHARMABIZ
BlueRock Gets FDA RMAT For Parkinson`s Cell Therapy Bemdaneprocel
31 May 2024 //
INDINPHARMAPOST
Tavros achieves milestones in collaboration with Bayer’s Vividion
14 May 2024 //
BIOSPACE
US FDA grants Fast Track Designation to AskBio’s AB-1002
19 Apr 2024 //
PHARMABIZ
AskBio Ph1b 18-Month AB-1005 Gene Therapy Data in Parkinson`s
16 Apr 2024 //
PRESS RELEASE
More revamp at Bayer as it axes 90 at its U.S. headquarters in New Jersey
27 Mar 2024 //
FIERCE PHARMA
Bayer ups its ante in radiopharma, signing on with PanTera
14 Feb 2024 //
FIERCE PHARMA
First patient in AskBio Phase II gene therapy trial for congestive heart failure
13 Feb 2024 //
PRESS RELEASE
Trinity Biotech Announces Entry into a Letter of Intent with Bayer
31 Jan 2024 //
GLOBENEWSWIRE
Application for regulatory approval of Aflibercept 8 mg accepted in China
24 Jan 2024 //
PRESS RELEASE
Bayer and AskBio reveal early safety data for Parkinson`s gene therapy
04 Jan 2024 //
ENDPTS
Bayer checks off another early win for gene therapy unit
04 Jan 2024 //
FIERCE BIOTECH
